Brain Advance Access originally published online on June 30, 2006
Brain 2006 129(10):2679-2687; doi:10.1093/brain/awl166
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy
1 Institute of Neurological Sciences, National Research Council Mangone (Cosenza), Italy 2 Dipartimento di Medicina Clinica e Biotecnologia Applicata D. Campanacci, Universita'di Bologna Bologna, Italy 3 Dipartimento dell'Area Radiologica, Policlinico S. Orsola Bologna, Italy 4 Institute of Neurology, University Magna Graecia Catanzaro, Italy 5 Department of Neuroscience, Psychiatry and Anesthesiology, University of Messina, Policlinico Universitario Italy 6 Department of Neurological Sciences, University Federico II Naples, Italy 7 Present address: Clinica Neurologica I, Dipartimento di Neuroscienze, Università di Catania Catania, Italy
Correspondence to: Raffaele Lodi, MD, Dipartimento di Medicina Clinica e Biotecnologia Applicata "D. Campanacci", "Universita" di Bologna, Policlinico S. Orsola, Via Massarenti 9, 40138 Bologna, Italy E-mail: raffaele.lodi{at}unibo.it
Clinical differentiation of parkinsonian syndromes such as the Parkinson variant of multiple system atrophy (MSA-P) and progressive supranuclear palsy (PSP) from Parkinson's disease is difficult in the early stage of the disease. In order to identify objective markers for differential diagnosis, we studied these three groups of patients with diffusion-weighted MRI (DWI). Sixteen MSA-P patients, 16 with PSP, 16 with Parkinson's disease and 15 healthy volunteers were studied. Regional apparent diffusion coefficients (rADC) were determined in different brain regions including basal ganglia, thalamus, white matter, pons and middle cerebellar peduncles (MCPs). rADC calculated in the MCP completely differentiated MSA-P patients (median: 0.93 x 103 mm2/s) from PSP patients (median: 0.82 x 103 mm2/s, P < 0.001), Parkinson's disease patients (median: 0.79 x 103 mm2/s, P < 0.001) and healthy volunteers (median: 0.81 x 103 mm2/s, P < 0.001). Other regions considered showed an overlapping among groups. DWI discriminates MSA-P from PSP and Parkinson's disease and healthy volunteers on the basis of MCP rADC values. These in vivo results confirm the pathological findings that the majority of MSA-P patients have moderate or severe degenerative changes not only in the nigrostriatal but also in the olivopontocerebellar systems. Our findings indicate that, in order to substantially contribute to the in vivo differential diagnosis of MSA-P, PSP and Parkinson's disease, rADC measurements should not be limited to the basal ganglia but should also include the MCP.
Key Words: diffusion imaging; middle cerebellar peduncle; multiple system atrophy; progressive supranuclear palsy; Parkinson's disease
Abbreviations: ADC, apparent diffusion coefficient; DWI, diffusion-weighted imaging; EPI, echo planar imaging; MCP, middle cerebellar peduncle; MSA, multiple system atrophy; PPV, positive predictive values; PSP, progressive supranuclear palsy; rADC, regional ADC; ROI, region of interest
Received January 5, 2006. Revised May 22, 2006. Accepted May 24, 2006.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. Gattellaro, L. Minati, M. Grisoli, C. Mariani, F. Carella, M. Osio, E. Ciceri, A. Albanese, and M.G. Bruzzone White Matter Involvement in Idiopathic Parkinson Disease: A Diffusion Tensor Imaging Study AJNR Am. J. Neuroradiol., June 1, 2009; 30(6): 1222 - 1226. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Fortuna, P. Barboni, R. Liguori, M. L. Valentino, G. Savini, C. Gellera, C. Mariotti, G. Rizzo, C. Tonon, D. Manners, et al. Visual system involvement in patients with Friedreich's ataxia Brain, January 1, 2009; 132(1): 116 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Borroni, M. Malinverno, F. Gardoni, A. Alberici, L. Parnetti, E. Premi, U. Bonuccelli, M. Grassi, D. Perani, P. Calabresi, et al. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy Neurology, November 25, 2008; 71(22): 1796 - 1803. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rizzo, P. Martinelli, D. Manners, C. Scaglione, C. Tonon, P. Cortelli, E. Malucelli, S. Capellari, C. Testa, P. Parchi, et al. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease Brain, October 1, 2008; 131(10): 2690 - 2700. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gilman, G. K. Wenning, P. A. Low, D. J. Brooks, C. J. Mathias, J. Q. Trojanowski, N. W. Wood, C. Colosimo, A. Durr, C. J. Fowler, et al. Second consensus statement on the diagnosis of multiple system atrophy Neurology, August 26, 2008; 71(9): 670 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tessa, M. Giannelli, R. Della Nave, C. Lucetti, C. Berti, A. Ginestroni, U. Bonuccelli, and M. Mascalchi A Whole-Brain Analysis in De Novo Parkinson Disease AJNR Am. J. Neuroradiol., April 1, 2008; 29(4): 674 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.T. Karagulle Kendi, S. Lehericy, M. Luciana, K. Ugurbil, and P. Tuite Altered Diffusion in the Frontal Lobe in Parkinson Disease AJNR Am. J. Neuroradiol., March 1, 2008; 29(3): 501 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ito, W. Shirai, M. Asahina, and T. Hattori Clinical and Brain MR Imaging Features Focusing on the Brain Stem and Cerebellum in Patients with Myoclonic Epilepsy with Ragged-Red Fibers due to Mitochondrial A8344G Mutation AJNR Am. J. Neuroradiol., February 1, 2008; 29(2): 392 - 395. [Abstract] [Full Text] [PDF] |
||||


